Observational Trial With Leios/Alesse

This study has been completed.

First Received: May 31, 2007 Last Updated: December 7, 2007 History of Changes

Sponsor:	Wyeth
Information provided by:	Wyeth
ClinicalTrials.gov Identifier:	NCT00481650

Purpose

A prospective, observational study (Anwendungsbeobachtung [AWB]) of the prescribing and administration practices of German gynecologists with Leios® Dragées.

Condition	Intervention	Phase
Contraceptives, Oral, Combined	Drug: Leios/Alesse	Phase IV

Study Type:	Observational
Study Design:	Prospective
Official Title:	A Prospective Observation Study (Anwendungsbeobachtung [AWB]) of the Prescribing and Administration Practices of German Gynecologists With Leios® Dragées/Alesse

Resource links provided by NLM:

Drug Information available for: Ethinyl estradiol-norgestrel combination

U.S. FDA Resources

Further study details as provided by Wyeth:

Study Start Date:	May 2005
Study Completion Date:	March 2007

Eligibility

Ages Eligible for Study:	up to 40 Years
Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

Healthy, women, aged under 40

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00481650

Sponsors and Collaborators

Wyeth

Investigators

Study Director:	Medical Monitor	Wyeth
Principal Investigator:	Trial Manager	For Germany, medinfoDEU@wyeth.com

More Information

No publications provided

Study ID Numbers:	101742
Study First Received:	May 31, 2007
Last Updated:	December 7, 2007
ClinicalTrials.gov Identifier:	NCT00481650 History of Changes
Health Authority:	Germany: Federal Institute for Drugs and Medical Devices

Additional relevant MeSH terms:

Contraceptives, Oral, Combined
Contraceptives, Postcoital, Synthetic
Contraceptive Agents
Therapeutic Uses
Physiological Effects of Drugs
Contraceptives, Oral

Contraceptive Agents, Female
Contraceptives, Oral, Synthetic
Ethinyl Estradiol-Norgestrel Combination
Reproductive Control Agents
Contraceptives, Postcoital
Pharmacologic Actions

ClinicalTrials.gov processed this record on November 27, 2009